Neurology news and neurology widget

WHAT: Today, Thursday, October 23, the New England Journal of medicine publish the results of the Phase II clinical trial comparing the investigational compound alemtuzumab against an approved therapy in early, relapsing-remitting multiple sclerosis patients. The investigational compound targets the root cause of multiple sclerosis, the immune system cells that attack the central nervous system.

The University of Illinois at Chicago College of Pharmacy has received a four-year, $1.87 million grant from the National Institutes of health to continue research into discovering a new drug class that will treat Alzheimer's disease.

A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS). The study, led by researchers from the University of Cambridge, has found that alemtuzumab not only stops MS from advancing in patients with early stage active relapsing-remitting multiple sclerosis (RRMS) but may also restore lost function caused by the disease.

A new study reveals how the brain can connect discrete but overlapping experiences to provide a rich integrated history that extends far beyond individually experienced events and may help to direct future choices. The research, published by Cell Press in the October 23rd issue of the journal Neuron, also explains why some people are good at generalizing from past experience, while others are not.

BOSTON (MedPage Today) -- Smokers with attention deficit hyperactivity disorder are more likely to become seriously addicted to nicotine, researchers reported here.

Life exists at the edge of chaos, where small changes can have striking and unanticipated effects, and major stimuli may go unheard. But there is no space for ambiguity when the brain needs to transform head motion into precise eye, head, and body movements that rapidly stabilize our posture and gaze; otherwise, we would stumble helplessly through the world, and our vision would resemble an undecipherable blur.

Targeted memory erasure is no longer limited to the realm of science fiction. A new study describes a method through which a selected set of memories can be rapidly and specifically erased from the mouse brain in a controlled and inducible manner.

A brain isn't born fully organized. It builds its abilities through experience, making physical connections between neurons and organizing circuits to store and retrieve information in milliseconds for years afterwards. Now that process has been caught in the act for the first time by a Duke University research team that watched a naïve brain organize itself to interpret images of motion.

Scientists have identified a gene in mice that plays a central role in the proper development of one of the nerve cells that goes bad in amyotrophic lateral sclerosis, or Lou Gehrig's disease, and some other diseases that affect our motor neurons. The study is the result of a collaboration by scientists at the University of rochester medical Center who normally focus on the eye, working together with a developmental neuroscientist at Harvard who focuses on the cerebral cortex.

A brain isn't born fully organized. It builds its abilities through experience, making physical connections between neurons and organizing circuits to store and retrieve information in milliseconds for years afterwards. Now that process has been caught in the act for the first time by a Duke University research team that watched a nave brain organize itself to interpret images of motion........